News Headlines Article

Concern over the rising cost of insulin
Southern California Public Radio

The average price of insulin tripled between 2002 and 2013, according to a research letter published today in JAMA, and that has led to higher costs for diabetics. Meanwhile, the cost of noninsulin therapies has trended downward, the researchers found.

A major driver of the increasing cost is analog insulin, a man-made insulin developed in the 1990s, according to the study. Analog insulin is considered superior to the other man-made insulin, known as human insulin, which was first engineered in the 1980s to to be genetically identical to the body’s naturally-produced insulin.